By Ken Perez, President, ScriptPro
Moves by the Trump administration to reduce HHS’s discretionary budget by 26.2% could have unintended adverse consequences. They not only could undermine the nation’s standing in the field of medical research, but also could derail progress in human health advances, promising medical findings, and public health preparedness. Cuts to discretionary spending by the National Institutes of Health (NIH) pose a particularly significant threat in this regard, because they ignore the NIH’s enormous potential for advancing scientific knowledge and medical advancement that benefit global health.
